About AMM

Mission

The Alliance for mRNA Medicines (AMM) is the leading global organization dedicated to advancing and advocating for mRNA and next-generation encoding RNA therapeutics and vaccines for the benefit of patients, public health, and society. Our mission is to propel the future of mRNA medicine, improve patients’ lives, and advance scientific knowledge by convening and empowering mRNA industry leaders, innovators, scientists, and other key stakeholders.

Executive Committee

Andrew Geall

Board Chair
Replicate Bioscience

Roberta Duncan

Board Vice-Chair
CSL

Anshul Mangal

Board Treasurer
Project Farma and Precision ADVANCE

Kate Broderick

Board Secretary
Maravai Life Sciences

Mayealie Adams

At-Large Board Executive
Danaher

Andreas Kuhn

At-Large Board Executive
BioNTech

Board of Directors

Sia Anagnostou

Whywevax

Christian Cobaugh

Vernal

Jeff Coller

Johns Hopkins University

Daria Donati

Danaher

Fred Fiedorek

Verve Therapeutics 

Robert Georgantas

Providence Therapeutics

Jack Horgan

MaxCyte

Francois Kerendi

CureVac

Yong Jae Kim

De novo Biotherapeutics 

Thomas Langenickel

Ethris

Remo Moomiaie-Qajar

Cytonus

Chris Murphy

Akron Biotech

Vicent Nebot

Curapath

Gloria Olivier

Mayo Clinic

Joe Petroziello

MJH Life Sciences

Francis Poulin

Sail Biomedicines

Thomas Preiss

Australian National University

Baley Reeves

Texas A&M Engineering Experiment Station

Guillaume Roelandts

Quantoom

Bernard Sagaert

etherna

Sarit Schwartz

Ginkgo Bioworks

Ying Tam

Acuitas Therapeutics

Patrick Thiaville

Exothera

Ian Wiener

Nutcracker

Ye Zhang

Arcturus Therapeutics

Our Team

Clay Alspach

Executive Director

Sara Singleton

Managing Director

Morrie Ruffin

Senior Advisor

Our Members

AMM members represent some of the most recognized mRNA innovators in the field. Bringing the best minds together, we aim to overcome the most critical obstacles inhibiting the advancement of mRNA research, development and manufacturing.

Why Should You Join AMM?

Interested in becoming a member of AMM? Check out the benefits of membership below.  

Policy Leadership

Leverage the combined strength of the global mRNA community to define and advance the sector’s top policy priorities before influential legislative leaders in North America, Europe, and Asia.

Regulatory Support

Accelerate your projects through our proactive engagement with regulatory agencies, working towards the swift approval of new mRNA therapeutics and vaccines. Spearhead global efforts to establish quality manufacturing standards and metrics.

Innovation and Technology

In the rapidly advancing world of mRNA and RNA medicines, AMM members gain exclusive insights into the cutting-edge technology and research driving our sector forward. AMM promotes technological collaborations between our members and leading tech innovators worldwide, and invites members to take part in AMM’s Science and Technology work groups.

Market Insights

Our comprehensive awareness and education program increases understanding of mRNA and next-generation encoding RNA therapeutics and vaccines’ potential. Our global communications strategy educates the marketplace and policy arenas, and offers members timely, relevant, and impactful industry news.

A Thriving Network

Connect with our community of innovators, therapeutic developers, and key opinion leaders at AMM’s exclusive networking events. From our annual flagship meeting to smaller regional roundtables, you’ll engage with experts and leaders shaping the industry.

Data at Your Fingertips

Gain unparalleled access to our growing industry data resources — a robust collection of third-party sources and our own proprietary research. Access global mRNA and next-generation RNA research, investments, and insights. From clinical to financial data, we will ensure you have the knowledge to track sector progress through our regular reports.

Workforce Development

Through our partnerships with industry stakeholders, we’re committed to nurturing talent with resources dedicated to training and development. Equip your team with the skills needed to drive your organization forward.

Investor Access

AMM partners with investor groups and financial institutions — critical connections that can support your organization’s capacity to secure capital for R&D — and invites members to join focused investor events, attracting investment for your initiatives.